Raymond James & Associates Profound Medical Corp. Transaction History

Raymond James & Associates

$161 Billion
Q3 2024

A detailed history of Raymond James & Associates transactions in Profound Medical Corp. stock. As of the latest transaction made, Raymond James & Associates holds 43,005 shares of PROF stock, worth $323,397. This represents 0.0% of its overall portfolio holdings.

Number of Shares

43,005

Previous 38,915 10.51%

Holding current value

$323,397

Previous $326,000 4.91%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 18, 2024	BUY	$7.47 - $11.18 $30,552 - $45,726	4,090 Added 10.51%	43,005 $342,000
Q2 2024 Jul 19, 2024	SELL	$7.25 - $9.07 $80,221 - $100,359	-11,065 Reduced 22.14%	38,915 $326,000
Q1 2024 Apr 22, 2024	SELL	$7.3 - $9.46 $114,704 - $148,644	-15,713 Reduced 23.92%	49,980 $426,000
Q4 2023 Jan 16, 2024	SELL	$7.85 - $11.18 $15,998 - $22,784	-2,038 Reduced 3.01%	65,693 $557,000
Q3 2023 Oct 24, 2023	BUY	$7.91 - $13.27 $40,538 - $68,008	5,125 Added 8.19%	67,731 $690,000
Q2 2023 Jul 25, 2023	BUY	$9.27 - $14.88 $36,570 - $58,701	3,945 Added 6.73%	62,606 $814,000
Q1 2023 Apr 14, 2023	SELL	$8.85 - $13.27 $307,015 - $460,349	-34,691 Reduced 37.16%	58,661 $544,000
Q4 2022 Feb 08, 2023	BUY	$3.18 - $10.91 $123,196 - $422,664	38,741 Added 70.94%	93,352 $1.02 Million
Q3 2022 Oct 25, 2022	SELL	$3.99 - $9.3 $27,411 - $63,891	-6,870 Reduced 11.17%	54,611 $221,000
Q2 2022 Aug 12, 2022	BUY	$6.34 - $9.53 $5,293 - $7,957	835 Added 1.38%	61,481 $448,000
Q1 2022 May 11, 2022	SELL	$8.16 - $11.33 $108,372 - $150,473	-13,281 Reduced 17.97%	60,646 $546,000
Q4 2021 Feb 08, 2022	BUY	$10.38 - $15.2 $85,437 - $125,111	8,231 Added 12.53%	73,927 $834,000
Q3 2021 Nov 02, 2021	BUY	$13.6 - $17.88 $151,449 - $199,111	11,136 Added 20.41%	65,696 $958,000
Q2 2021 Aug 11, 2021	BUY	$16.0 - $20.59 $304,864 - $392,321	19,054 Added 53.66%	54,560 $888,000
Q1 2021 May 14, 2021	BUY	$19.16 - $28.09 $269,504 - $395,113	14,066 Added 65.61%	35,506 $712,000
Q4 2020 Feb 12, 2021	SELL	$16.4 - $22.9 $32,488 - $45,364	-1,981 Reduced 8.46%	21,440 $441,000
Q3 2020 Nov 04, 2020	BUY	$14.05 - $18.13 $329,065 - $424,622	23,421 New	23,421 $412,000
Q2 2020 Jul 28, 2020	SELL	$9.41 - $16.94 $97,864 - $176,176	-10,400 Closed	0 $0
Q1 2020 Apr 21, 2020	BUY	$6.88 - $19.7 $71,552 - $204,880	10,400 New	10,400 $100,000

Others Institutions Holding PROF

# of Institutions

Shares Held

8.93M

Call Options Held

1.2K

Put Options Held

View Full List

About Profound Medical Corp.

Ticker PROF
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 20,851,300
Market Cap $157M
Description
Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops magnetic resonance guided ablation procedures for treatment of prostate disease, uterine fibroids, and palliative pain treatment in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system used for...

More about PROF

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.

Account

Raymond James & Associates Profound Medical Corp. Transaction History